Maplelane Capital LLC Buys New Position in Hyperliquid Strategies Inc $PURR

Maplelane Capital LLC purchased a new position in Hyperliquid Strategies Inc (NASDAQ:PURR) during the 1st quarter, HoldingsChannel reports. The firm purchased 575,000 shares of the company’s stock, valued at approximately $2,927,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Boothbay Fund Management LLC bought a new position in shares of Hyperliquid Strategies during the 4th quarter valued at about $40,000. XTX Topco Ltd bought a new stake in shares of Hyperliquid Strategies in the 4th quarter worth approximately $48,000. Private Advisor Group LLC acquired a new stake in Hyperliquid Strategies during the first quarter valued at approximately $83,000. Squarepoint Ops LLC acquired a new stake in Hyperliquid Strategies during the fourth quarter valued at approximately $73,000. Finally, SG Americas Securities LLC bought a new stake in Hyperliquid Strategies during the first quarter worth approximately $117,000. 9.45% of the stock is owned by institutional investors and hedge funds.

Hyperliquid Strategies Price Performance

PURR opened at $6.19 on Friday. The firm has a fifty day simple moving average of $8.27. The stock has a market capitalization of $894.15 million, a price-to-earnings ratio of -0.84 and a beta of 1.66. Hyperliquid Strategies Inc has a 12-month low of $3.01 and a 12-month high of $11.62.

Hyperliquid Strategies (NASDAQ:PURR) last issued its earnings results on Thursday, May 7th. The company reported $1.01 EPS for the quarter. The business had revenue of $2.63 million during the quarter. On average, equities analysts expect that Hyperliquid Strategies Inc will post 2.1 earnings per share for the current year.

Analysts Set New Price Targets

PURR has been the topic of several recent research reports. Cantor Fitzgerald lifted their price target on shares of Hyperliquid Strategies from $8.00 to $18.40 and gave the stock an “overweight” rating in a research report on Wednesday, July 1st. Maxim Group initiated coverage on Hyperliquid Strategies in a research note on Friday, April 24th. They set a “buy” rating and a $10.00 price objective for the company. Weiss Ratings upgraded Hyperliquid Strategies from a “sell (d)” rating to a “sell (d+)” rating in a report on Wednesday, June 3rd. Finally, Chardan Capital reaffirmed a “buy” rating and set a $9.75 target price on shares of Hyperliquid Strategies in a research report on Friday, June 12th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, Hyperliquid Strategies has an average rating of “Moderate Buy” and an average target price of $12.72.

About Hyperliquid Strategies

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.